LightPath's own 10-K says BD6 is generic. What is left is a better thesis, plus a related-party China sale with a margin ratchet and a lock-up expiring this week.
LPTH currently has a backlog well over $110 million with many other proposals filed. Also, on June 2nd, LPTH had a $100 million Direct, secondary Offering of which $50 million went to LPTH and $50 million was sold by North Run Strategic Opportunities Fund 1. Is their still more? Please understand that I truly appreciate all that you do to assist us in our equity decisions but you have a wide range of companies that you analyze and I am just trying to help because I fully understand LPTH and Its potential.
So Part 2 comes after the annual report in late September?
LPTH currently has a backlog well over $110 million with many other proposals filed. Also, on June 2nd, LPTH had a $100 million Direct, secondary Offering of which $50 million went to LPTH and $50 million was sold by North Run Strategic Opportunities Fund 1. Is their still more? Please understand that I truly appreciate all that you do to assist us in our equity decisions but you have a wide range of companies that you analyze and I am just trying to help because I fully understand LPTH and Its potential.
Thanks
Actually we had a subscriber reach out to us with the backlog updates and we updated our post.